- Fund Type: FCP
- Objective: Growth and Income
- Asset Class: Equity
- Geographic Focus: Euro Countries
Snapshot for Ambiose (AFAFAMP)
| Year To Date: | +2.22% | 3-Month: | -3.21% | 3-Year: | -2.71% | 52-Week Range: | 7.71 - 10.31 |
|---|---|---|---|---|---|---|---|
| 1-Month: | -4.83% | 1-Year: | +25.62% | 5-Year: | -7.11% | Beta vs LCXE: | 1.06 |
Fund Profile & Information for AFAFAMP
Ambiose is an open-end fund registered in France. The Fund objective is to outperform the CAC 40 Index over a long-term period. The Fund invests at least 60 percent of its assets in stocks from Euro countries. The Fund may also invest up to five percent of its assets in other OPCVMs. The Fund is eligible for the PEA.
| Inception Date: | 12-24-2003 | Telephone: | Tel: 33 01 70 08 08 00 |
|---|---|---|---|
| Managers: | - | ||
| Web Site: | www.avenirfinance.fr | ||
Fundamentals for AFAFAMP
| NAV | (on 2013-06-17) 9.73 |
|---|---|
| Assets (M) | (on 2013-06-14) 31.13 |
| Fund Leveraged | N |
| Minimum Investment | - |
| Minimum Subsequent Investment | - |
Dividends for AFAFAMP
No dividends reported
Fees & Expenses for AFAFAMP
| Front Load | 4.75 |
|---|---|
| Back Load | 0.00 |
| Current Mgmt Fee | 2.15 |
| Redemption Fee | 0.00 |
| 12b1 Fee | - |
| Expense Ratio | - |
Top Fund Holdings for AFAFAMP
Filing Date: 04/30/2013| Name | Position | Value | % of Total |
|---|---|---|---|
| Anheuser-Busch InBev NV | 9,845 | 711,301 | 2.607% |
| Sanofi | 8,124 | 676,079 | 2.478% |
| Total SA | 15,691 | 600,495 | 2.201% |
| Siemens AG | 6,477 | 513,626 | 1.883% |
| L'Oreal SA | 3,785 | 512,489 | 1.879% |
| LVMH Moet Hennessy Louis Vuitt | 3,868 | 508,642 | 1.865% |
| Eni SpA | 27,160 | 493,226 | 1.808% |
| SAP AG | 7,786 | 469,574 | 1.721% |
| Bayer AG | 5,421 | 429,452 | 1.574% |
| Inditex SA | 4,070 | 415,344 | 1.523% |
Quotes delayed, except where indicated otherwise. Mutual fund NAVs include dividends. All prices in local currency. Time is ET.
Sponsored Financial Commentaries
Advertisement
Top Forex Trading Resources
- 1
- 2
- 3
- 4
- 5
Advertisement
Advertisement
Sponsored Links
Advertisements
Rate this Page